Artios is a leading independent DDR Company with a strong pipeline of novel cancer therapies in development with first-in-class & best-in-class potential.
Location: United Kingdom, England, Cambridge
Member count: 51-200
Total raised: $153M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 27.07.2021 | Series C | $153M | - | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 10.08.2022 | Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in ... | CAMBRIDGE, UK and NEW YORK, USA, 10 August 2022: Artios Pharma Limited (Artios), a clinical stage bi... | svhealthin... |